Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumors in children

R J Packer1

  • 1Children's National Medical Center, Department of Neurology, Washington, DC 20010, USA.

Current Opinion in Pediatrics
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Childhood brain tumors remain challenging to treat, with slow progress in outcomes. Current treatments like chemotherapy and radiotherapy show limited success for aggressive types, highlighting unmet needs in pediatric neuro-oncology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.

AJNR. American journal of neuroradiology·2019
Same author

Treatment of pediatric cerebral radiation necrosis: a systematic review.

Journal of neuro-oncology·2016
Same author

Remarkable oxide ion conductivity observed at low temperatures in a complex superstructured oxide.

Advanced materials (Deerfield Beach, Fla.)·2010
Same author

CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis.

Neurology·2007
Same author

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

Neurology·2007
Same author

Treatment strategies for medulloblastoma and primitive neuroectodermal tumors.

Neurosurgical focus·2006
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Neuro-Oncology
  • Cancer Biology

Background:

  • Childhood brain tumors represent the most frequent pediatric solid neoplasms.
  • Treatment advancements lag significantly behind other childhood cancers.
  • The underlying biology of pediatric brain tumors is still under investigation.

Purpose of the Study:

  • To review the current state of childhood brain tumor treatment.
  • To highlight the role of chemotherapy and radiotherapy in managing these tumors.
  • To identify challenges and unmet needs in pediatric brain tumor therapy.

Main Methods:

  • Review of existing literature on pediatric brain tumor treatment.
  • Analysis of treatment strategies including chemotherapy and radiotherapy.

Related Experiment Videos

  • Evaluation of outcomes for different types of pediatric brain tumors.

    • Main Results:

    • Chemotherapy is a key treatment modality for many pediatric central nervous system tumors.
    • Despite intensified treatment protocols, outcomes for brain stem gliomas and high-grade cortical gliomas are poor.
    • Significant challenges persist in the optimal management of childhood low-grade gliomas.

    Conclusions:

    • Pediatric brain tumor treatment requires further innovation.
    • Improved therapeutic strategies are crucial for better survival rates.
    • Further research into tumor biology and treatment optimization is essential.